UBS analyst maintained a Buy rating on JD Health International, Inc. on July 3 and set a price target of HK$61.90. The company’s shares closed yesterday at HK$36.10.
4th of July Sale – 70% Off
Unlock powerful investing tools and data-driven insights … [632 chars]
JD Health International, Inc. (6618) Receives a Buy from UBS
